RKDA
Arcadia Biosciences, Inc.NASDAQBasic MaterialsAs of 2026-04-07
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.43
P/S
0.37
EV/EBITDA
-0.47
DCF Value
$-45.67
FCF Yield
-266.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
36.2%
Operating Margin
-51.4%
Net Margin
-48.1%
ROE
-40.6%
ROA
-35.7%
ROIC
-55.7%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $901.0K | $-1.3M | $-0.98 |
| FY 2025 | $4.9M | $-2.3M | $-1.71 |
| Q3 2025 | $1.3M | $856.0K | $0.62 |
| Q2 2025 | $1.5M | $-4.5M | $-3.26 |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$6.00
Target (Median)
$6.00
Target Range
$6.00 - $6.00
Trading Activity
Insider Trades
View AllCompany Info
Sector
Basic Materials
Industry
—
Country
US
Exchange
NASDAQ
Beta
0.72
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.